Ingrid Kane

Direttore Tecnico/Scientifico/R&S presso SIGHT SCIENCES, INC.

Health Technology

Health Services

Consumer Services

Profilo

Ingrid Kane is currently the Vice President-Global Medical Affairs at Sight Sciences, Inc. Previously, she worked as the Vice President-Medical Affairs at iScience Interventional Corp.
She holds a doctorate degree from the University of Charles.

Posizioni attive di Ingrid Kane

Società	Posizione	Inizio
SIGHT SCIENCES, INC.	Direttore Tecnico/Scientifico/R&S	-

Tutte le posizioni attive di Ingrid Kane

Precedenti posizioni note di Ingrid Kane

Società	Posizione	Fine
iScience Interventional Corp. iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Ingrid Kane

Formazione di Ingrid Kane

University of Charles

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ingrid Kane

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
SIGHT SCIENCES, INC.	Health Technology

Aziende private	1
iScience Interventional Corp. iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA.	Health Services